Canadian Pharmaceuticals & Biotech Most Popular Stocks

Hemostemix

Market Cap: CA$11.9m

A clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada.

LIR Life Sciences

Market Cap: CA$10.6m

Operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders.

Marvel Biosciences

Market Cap: CA$10.1m

A biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada.

Red White & Bloom Brands

Market Cap: CA$9.4m

Manufactures and distributes cannabis products and accessories in the United States, Canada, and internationally.

PreveCeutical Medical

Market Cap: CA$9.2m

A health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products.

Glow Lifetech

Market Cap: CA$8.7m

An ingredient technology company, focuses on producing nutraceutical and cannabinoid-based products.

Nextleaf Solutions

Market Cap: CA$8.5m

A cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada.

Avant Brands

Market Cap: CA$8.0m

Avant Brands Inc. cultivates, produces, markets, and sells cannabis products in Canada.

Sweet Earth Holdings

Market Cap: CA$6.6m

Does not have significant operations.

Simply Solventless Concentrates

Market Cap: CA$6.4m

Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.

Christina Lake Cannabis

Market Cap: CA$6.2m

A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.

Kane Biotech

Market Cap: CA$6.2m

A biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally.

Herbal Dispatch

Market Cap: CA$5.6m

Engages in the sale of cannabis and cannabis related products in Canada and internationally.

MYND Life Sciences

Market Cap: CA$5.2m

A life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States.

Restart Life Sciences

Market Cap: CA$5.2m

Through its subsidiaries, operates as a biotechnology company in Canada.

StageZero Life Sciences

Market Cap: CA$4.9m

A vertically integrated healthcare company, develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications in North America and Western Europe.

PharmaTher Holdings

Market Cap: CA$5.0m

A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.

XORTX Therapeutics

Market Cap: CA$5.0m

A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat hyperuricemia related diseases in Canada.

Blueberries Medical

Market Cap: CA$5.0m

A consumer science company, engages in the commercialization of medicinal cannabis and related products in Colombia.

Innovotech

Market Cap: CA$4.9m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

Quest PharmaTech

Market Cap: CA$4.2m

A pharmaceutical company, develops targeted cancer therapies in Canada.

Grey Matters Health

Market Cap: CA$4.2m

Operates as a clinical stage pharmaceutical development company in Canada and Australia.

Telo Genomics

Market Cap: CA$4.0m

A molecular diagnostics company, engages in the development and commercialization of predictive technological products to personalize treatment plans for patients with specific conditions, primarily in Canada.

Delivra Health Brands

Market Cap: CA$3.4m

Through its subsidiaries, engages in the health and wellness consumer packaged goods business worldwide.

Rakovina Therapeutics

Market Cap: CA$3.2m

A biopharmaceutical research company, engages in the research and development of cancer treatments that target DNA-damage response systems.

BioVaxys Technology

Market Cap: CA$3.1m

A clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.

City View Green Holdings

Market Cap: CA$2.7m

A consumer-packaged goods company, formulates, produces, and sells cannabis edibles and related products in Canada.

1933 Industries

Market Cap: CA$2.6m

Engages in the cultivation, extraction, and production of cannabis products in the United States.

Aion Therapeutic

Market Cap: CA$2.5m

Engages in the health and wellness business in the United States.

Moss Genomics

Market Cap: CA$2.2m

A biotechnology company focused on genomics and microbiome research to develop advanced genetic insights and solutions in Canada.

CanadaBis Capital

Market Cap: CA$2.1m

Engages in the production and sale of recreational cannabis and cannabis extracts in Canada.

Appili Therapeutics

Market Cap: CA$2.0m

A biopharmaceutical company, focuses on the acquisition and development of treatments targeting unmet needs in infectious diseases in the United States and Canada.

Psyence Group

Market Cap: CA$1.9m

A life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma.

Neural Therapeutics

Market Cap: CA$1.7m

An ethnobotanical drug discovery and development company, develops over-the-counter dietary supplements and psychedelic-based therapeutic drugs to treat mental illnesses in Canada.

Silo Wellness

Market Cap: CA$1.5m

A psychedelics and wellness company, develops psychedelic medicine to reduce trauma.

MindBio Therapeutics

Market Cap: CA$1.5m

Engages in researching, developing, and testing psychedelic substances as a potential treatment for the management of various mental health conditions in Australasia.